{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:01:36Z","timestamp":1793275296725,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100013213","name":"ARUP Institute for Clinical and Experimental Pathology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013213","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-169152"],"award-info":[{"award-number":["PJT-169152"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.cca.2023.117295","type":"journal-article","created":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T15:54:44Z","timestamp":1678550084000},"page":"117295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Quantitative analysis of ethanolamine plasmalogen species in red blood cells using liquid chromatography tandem mass spectrometry for diagnosing peroxisome biogenesis disorders"],"prefix":"10.1016","volume":"542","author":[{"given":"Irene","family":"De Biase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Yuzyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Zuromski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann B.","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Braverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2\u20133","key":"10.1016\/j.cca.2023.117295_b0005","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbalip.2003.12.010","article-title":"Functions and biosynthesis of plasmalogens in health and disease","volume":"1636","author":"Brites","year":"2004","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/j.cca.2023.117295_b0010","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.bbadis.2012.05.008","article-title":"Functions of plasmalogen lipids in health and disease","volume":"1822","author":"Braverman","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"10.1016\/j.cca.2023.117295_b0015","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bbalip.2008.07.008","article-title":"Mass spectrometric analysis of lipid species of human circulating blood cells","volume":"1781","author":"Leidl","year":"2008","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"10.1016\/j.cca.2023.117295_b0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0005-2760(97)00120-3","article-title":"Dihydroxyacetone phosphate acyltransferase","volume":"1348","author":"Hajra","year":"1997","journal-title":"Biochim Biophys Acta"},{"issue":"15","key":"10.1016\/j.cca.2023.117295_b0025","first-page":"8835","article-title":"Alkyldihydroxyacetone-P synthase","volume":"257","author":"Brown","year":"1982","journal-title":"Solubilization, partial purification, new assay method, and evidence for a ping-pong mechanism, J Biol Chem"},{"issue":"5","key":"10.1016\/j.cca.2023.117295_b0030","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ajhg.2014.10.003","article-title":"A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency","volume":"95","author":"Buchert","year":"2014","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.cca.2023.117295_b0035","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ng0497-369","article-title":"Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata","volume":"15","author":"Braverman","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.cca.2023.117295_b0040","doi-asserted-by":"crossref","unstructured":"I. De Biase, S. Tortorelli, L. Kratz, J.S. S, K. Cusmano-Ozog, N. Braverman, A.L.Q.A. Committee, Laboratory diagnosis of disorders of peroxisomal biogenesis and function: a technical standard of the American College of Medical Genetics and Genomics (ACMG), Genet Med 22(4) (2020) 686-697.","DOI":"10.1038\/s41436-019-0713-9"},{"key":"10.1016\/j.cca.2023.117295_b0045","unstructured":"N.E. Braverman, S.J. Steinberg, W. Fallatah, A. Duker, M. Bober, Rhizomelic Chondrodysplasia Punctata Type 1, in: M.P. Adam, D.B. Everman, G.M. Mirzaa, R.A. Pagon, S.E. Wallace, L.J.H. Bean, K.W. Gripp, A. Amemiya (Eds.), GeneReviews((R)), Seattle (WA), 1993."},{"issue":"4","key":"10.1016\/j.cca.2023.117295_b0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/MCD.0b013e3282fdcc70","article-title":"Chondrodysplasia punctata: a clinical diagnostic and radiological review","volume":"17","author":"Irving","year":"2008","journal-title":"Clin Dysmorphol"},{"issue":"3","key":"10.1016\/j.cca.2023.117295_b0055","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ajmg.a.61413","article-title":"Rhizomelic chondrodysplasia punctata morbidity and mortality, an update","volume":"182","author":"Duker","year":"2020","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.cca.2023.117295_b0060","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/jimd.12349","article-title":"Clinical, biochemical, and molecular characterization of mild (nonclassic) rhizomelic chondrodysplasia punctata","volume":"44","author":"Fallatah","year":"2021","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.cca.2023.117295_b0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymgme.2015.12.009","article-title":"Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines","volume":"117","author":"Braverman","year":"2016","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.1016\/j.cca.2023.117295_b0070","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/humu.10124","article-title":"Mutation analysis of PEX7 in 60 probands with rhizomelic chondrodysplasia punctata and functional correlations of genotype with phenotype","volume":"20","author":"Braverman","year":"2002","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cca.2023.117295_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.946393","article-title":"Regulation of plasmalogen metabolism and traffic in mammals: The fog begins to lift","volume":"10","author":"Dorninger","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.cca.2023.117295_b0080","doi-asserted-by":"crossref","unstructured":"S. Steinberg, R. Jones, C. Tiffany, A. Moser, Investigational methods for peroxisomal disorders, Current protocols in human genetics Chapter 17 (2008) Unit 17 6.","DOI":"10.1002\/0471142905.hg1706s58"},{"issue":"7","key":"10.1016\/j.cca.2023.117295_b0085","doi-asserted-by":"crossref","first-page":"e21643","DOI":"10.1371\/journal.pone.0021643","article-title":"Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics","volume":"6","author":"Han","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cca.2023.117295_b0090","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10545-017-0114-7","article-title":"Plasma lipidomics as a diagnostic tool for peroxisomal disorders","volume":"41","author":"Herzog","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.cca.2023.117295_b0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpba.2016.11.019","article-title":"Accurate quantitation of choline and ethanolamine plasmalogen molecular species in human plasma by liquid chromatography-tandem mass spectrometry","volume":"134","author":"Otoki","year":"2017","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.cca.2023.117295_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.339088","article-title":"Structure-specific, accurate quantitation of plasmalogen glycerophosphoethanolamine","volume":"1186","author":"Morel","year":"2021","journal-title":"Anal Chim Acta"},{"issue":"16","key":"10.1016\/j.cca.2023.117295_b0105","doi-asserted-by":"crossref","first-page":"11268","DOI":"10.1021\/acs.analchem.0c01933","article-title":"Unequivocal Mapping of Molecular Ether Lipid Species by LC-MS\/MS in Plasmalogen-Deficient Mice","volume":"92","author":"Koch","year":"2020","journal-title":"Anal Chem"},{"issue":"10","key":"10.1016\/j.cca.2023.117295_b0110","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.jasms.2004.07.009","article-title":"Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids","volume":"15","author":"Zemski Berry","year":"2004","journal-title":"Journal of the American Society for Mass Spectrometry"},{"issue":"1","key":"10.1016\/j.cca.2023.117295_b0115","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.042499","article-title":"Oral administration of a synthetic vinyl-ether plasmalogen normalizes open field activity in a mouse model of rhizomelic chondrodysplasia punctata","volume":"13","author":"Fallatah","year":"2020","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.cca.2023.117295_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.886316","article-title":"A Pex7 Deficient Mouse Series Correlates Biochemical and Neurobehavioral Markers to Genotype Severity-Implications for the Disease Spectrum of Rhizomelic Chondrodysplasia Punctata Type 1","volume":"10","author":"Fallatah","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.cca.2023.117295_b0125","first-page":"289","article-title":"mclust 5: Clustering","volume":"8","author":"Scrucca","year":"2016","journal-title":"Classification and Density Estimation Using Gaussian Finite Mixture Models, R J"},{"key":"10.1016\/j.cca.2023.117295_b0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clinbiochem.2021.07.013","article-title":"Establishing age-stratified red blood cell fatty acid reference ranges using model-based clustering and iterative application of the harris-boyd method","volume":"97","author":"Balogun","year":"2021","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cca.2023.117295_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2020.102211","article-title":"Effect of fasting status and other pre-analytical variables on quantitation of long-chain fatty acids in red blood cells","volume":"163","author":"Lozier","year":"2020","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"1","key":"10.1016\/j.cca.2023.117295_b0140","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2023.117295_b0145","unstructured":"U. FDA, Bioanalytical method validation guidance for industry, US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research and Center for Veterinary Medicine (2018)."},{"key":"10.1016\/j.cca.2023.117295_b0150","unstructured":"R.C. Team, R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, http:\/\/www.R-project.org\/ (2019)."},{"key":"10.1016\/j.cca.2023.117295_b0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jchromb.2015.09.012","article-title":"MS\/MS and LC-MS\/MS analysis of choline\/ethanolamine plasmalogens via promotion of alkali metal adduct formation","volume":"1004","author":"Otoki","year":"2015","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"4","key":"10.1016\/j.cca.2023.117295_b0160","doi-asserted-by":"crossref","first-page":"e35102","DOI":"10.1371\/journal.pone.0035102","article-title":"Lipid composition of the human eye: are red blood cells a good mirror of retinal and optic nerve fatty acids?","volume":"7","author":"Acar","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cca.2023.117295_b0165","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1651-2227.2008.01205.x","article-title":"Plasmalogen levels in full-term neonates","volume":"98","author":"Labadaridis","year":"2009","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.cca.2023.117295_b0170","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1750-1172-8-174","article-title":"The neurology of rhizomelic chondrodysplasia punctata","volume":"8","author":"Bams-Mengerink","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.cca.2023.117295_b0175","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF01800482","article-title":"Age-related differences in plasmalogen content of erythrocytes from patients with the cerebro-hepato-renal (Zellweger) syndrome: implications for postnatal detection of the disease","volume":"9","author":"Wanders","year":"1986","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"10.1016\/j.cca.2023.117295_b0180","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/jmg.2009.074302","article-title":"Identification of an unusual variant peroxisome biogenesis disorder caused by mutations in the PEX16 gene","volume":"47","author":"Ebberink","year":"2010","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.cca.2023.117295_b0185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10545-008-0969-8","article-title":"A PEX10 defect in a patient with no detectable defect in peroxisome assembly or metabolism in cultured fibroblasts","volume":"32","author":"Steinberg","year":"2009","journal-title":"J Inherit Metab Dis"},{"issue":"7","key":"10.1016\/j.cca.2023.117295_b0190","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10038-007-0157-y","article-title":"A novel PEX12 mutation identified as the cause of a peroxisomal biogenesis disorder with mild clinical phenotype, mild biochemical abnormalities in fibroblasts and a mosaic catalase immunofluorescence pattern, even at 40 degrees C","volume":"52","author":"Zeharia","year":"2007","journal-title":"J Hum Genet"},{"key":"10.1016\/j.cca.2023.117295_b0195","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jmsacl.2021.09.004","article-title":"Rapid identification of plasmalogen molecular species using targeted multiplexed selected reaction monitoring mass spectrometry","volume":"22","author":"Azad","year":"2021","journal-title":"J Mass Spectrom Adv Clin Lab"},{"key":"10.1016\/j.cca.2023.117295_b0200","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1476-511X-10-101","article-title":"Human and great ape red blood cells differ in plasmalogen levels and composition","volume":"10","author":"Moser","year":"2011","journal-title":"Lipids Health Dis"},{"issue":"9","key":"10.1016\/j.cca.2023.117295_b0205","doi-asserted-by":"crossref","first-page":"e106912","DOI":"10.1371\/journal.pone.0106912","article-title":"Erythrocyte phospholipid and polyunsaturated fatty acid composition in diabetic retinopathy","volume":"9","author":"Koehrer","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2023.117295_b0210","unstructured":"I. De Biase, D.J. Ronnow, L. Duque Lasio, E. Kish-Trier, T. Yuzyuk, Does fatty acid content influence plasmalogen levels? Implications for the laboratory evaluation of peroxisomal disorders, 74th AACC Annual Scientific Meeting & Clinical Lab Expo, Chicago, IL,USA 2022, pp. A-248."},{"key":"10.1016\/j.cca.2023.117295_b0215","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.plipres.2019.04.003","article-title":"Plasmalogens: A potential therapeutic target for neurodegenerative and cardiometabolic disease","volume":"74","author":"Paul","year":"2019","journal-title":"Prog Lipid Res"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123000979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123000979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:09:19Z","timestamp":1757862559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898123000979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":43,"alternative-id":["S0009898123000979"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2023.117295","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative analysis of ethanolamine plasmalogen species in red blood cells using liquid chromatography tandem mass spectrometry for diagnosing peroxisome biogenesis disorders","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2023.117295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117295"}}